Annual EBITDA
Summary
- Current Value
- As of today, UHS annual EBITDA is $2.61B, up +15.27% on
- Historical Performance
- UHS annual EBITDA is up +59.03% over the past 3 years, up +39.91% over the past 5 years
- All-Time High Comparison
- UHS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- UHS annual EBITDA is +59.03% above its 3-year low of $1.64B reached on an earlier date
- Sector Comparison
- UHS annual EBITDA is higher than 95.98% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.61B | +15.3% | +59.0% | +39.9% | +234.2% | |
| Quarterly EBITDA | $680.57M | +9.9% | +66.1% | +24.2% | +178.3% | |
| TTM EBITDA | $2.61B | +15.3% | +64.8% | +39.8% | +225.1% | |
| Price | $194.78 | +9.6% | +53.2% | +48.3% | +308.7% | |
| PE Ratio | 8.41 | -20.4% | -39.4% | -29.5% | -58.5% | |
| Annual Revenue | $17.36B | +9.7% | +29.6% | +50.2% | +211.9% | |
| Annual EPS | $23.10 | +37.3% | +152.7% | +109.4% | +887.0% | |
| $1.99B | +18.6% | +87.9% | +46.9% | +257.4% | ||
| Annual Net Income | $1.51B | +29.9% | +130.3% | +59.1% | +449.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.61B | at high | |
| 5Y | $2.61B | at high | |
| All | $2.61B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.64B | N/A | +59.0% |
| 5Y | $1.64B | +59.0% | |
| All | $16.54M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of UHS?
As of today, UHS annual EBITDA is $2.61B
What is 1-year change in UHS annual EBITDA?
UHS annual EBITDA is up +15.27% year-over-year
What is 3-year change in UHS annual EBITDA?
UHS annual EBITDA is up +59.03% over the past 3 years
How far is UHS annual EBITDA from its all-time high?
UHS annual EBITDA is currently at its all-time high
How does UHS annual EBITDA rank versus sector peers?
UHS annual EBITDA is higher than 95.98% of companies in Healthcare sector
When is UHS next annual earnings release?
As of today, the next annual earnings release for UHS has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, UHS quarterly EBITDA is $680.57M, up +0.56% on
- Historical Performance
- UHS quarterly EBITDA is up +9.90% year-over-year, up +66.10% over the past 3 years
- All-Time High Comparison
- UHS quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- UHS quarterly EBITDA is +66.10% above its 3-year low of $409.74M reached on an earlier date
- Sector Comparison
- UHS quarterly EBITDA is higher than 96.25% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $680.57M | +0.6% | +9.9% | +66.1% | +24.2% | |
| Annual EBITDA | $2.61B | – | +15.3% | +59.0% | +39.9% | |
| TTM EBITDA | $2.61B | +2.4% | +15.3% | +64.8% | +39.8% | |
| Price | $194.78 | -15.7% | +9.6% | +53.2% | +48.3% | |
| PE Ratio | 8.41 | -23.4% | -20.4% | -39.4% | -29.5% | |
| Quarterly Revenue | $4.49B | -0.2% | +9.1% | +30.1% | +45.3% | |
| Quarterly EPS | $7.06 | +20.5% | +42.5% | +190.2% | +96.4% | |
| $517.23M | -0.8% | +9.5% | +97.9% | +24.9% | ||
| Quarterly Net Income | $447.84M | +18.1% | +32.9% | +163.1% | +46.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $680.57M | at high | |
| 3Y | $680.57M | at high | |
| 5Y | $680.57M | at high | |
| All | $680.57M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $603.17M | +12.8% | |
| 3Y | $409.74M | N/A | +66.1% |
| 5Y | $376.64M | +80.7% | |
| All | -$424.40M | +260.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of UHS?
As of today, UHS quarterly EBITDA is $680.57M
What is UHS quarterly EBITDA most recent change?
UHS quarterly EBITDA was up +0.56% on December 31, 2025
What is 1-year change in UHS quarterly EBITDA?
UHS quarterly EBITDA is up +9.90% year-over-year
How far is UHS quarterly EBITDA from its all-time high?
UHS quarterly EBITDA is currently at its all-time high
How does UHS quarterly EBITDA rank versus sector peers?
UHS quarterly EBITDA is higher than 96.25% of companies in Healthcare sector
When is UHS next earnings release?
The next earnings release for UHS is on
TTM EBITDA
Summary
- Current Value
- As of today, UHS TTM EBITDA is $2.61B, up +2.40% on
- Historical Performance
- UHS TTM EBITDA is up +15.27% year-over-year, up +64.80% over the past 3 years
- All-Time High Comparison
- UHS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- UHS TTM EBITDA is +64.80% above its 3-year low of $1.59B reached on an earlier date
- Sector Comparison
- UHS TTM EBITDA is higher than 96.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.61B | +2.4% | +15.3% | +64.8% | +39.8% | |
| Annual EBITDA | $2.61B | – | +15.3% | +59.0% | +39.9% | |
| Quarterly EBITDA | $680.57M | +0.6% | +9.9% | +66.1% | +24.2% | |
| Price | $194.78 | -15.7% | +9.6% | +53.2% | +48.3% | |
| PE Ratio | 8.41 | -23.4% | -20.4% | -39.4% | -29.5% | |
| TTM Revenue | $17.36B | +2.2% | +9.7% | +29.6% | +50.2% | |
| TTM EPS | $23.15 | +10.0% | +37.5% | +152.8% | +110.3% | |
| $1.99B | +2.3% | +18.6% | +98.7% | +46.8% | ||
| TTM Net Income | $1.51B | +7.9% | +29.9% | +130.3% | +59.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.61B | at high | |
| 3Y | $2.61B | at high | |
| 5Y | $2.61B | at high | |
| All | $2.61B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.27B | N/A | +15.3% |
| 3Y | $1.59B | N/A | +64.8% |
| 5Y | $1.59B | +64.8% | |
| All | -$197.00M | +1426.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of UHS?
As of today, UHS TTM EBITDA is $2.61B
What is UHS TTM EBITDA most recent change?
UHS TTM EBITDA was up +2.40% on December 31, 2025
What is 1-year change in UHS TTM EBITDA?
UHS TTM EBITDA is up +15.27% year-over-year
How far is UHS TTM EBITDA from its all-time high?
UHS TTM EBITDA is currently at its all-time high
How does UHS TTM EBITDA rank versus sector peers?
UHS TTM EBITDA is higher than 96.07% of companies in Healthcare sector
When is UHS next earnings release?
The next earnings release for UHS is on
EBITDA Formula
Data Sources & References
- UHS Official Website uhs.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/352915/000119312526071676/0001193125-26-071676-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/352915/000119312526071676/0001193125-26-071676-index.htm
- UHS Profile on Yahoo Finance finance.yahoo.com/quote/UHS
- UHS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/uhs
